Haroz E E, Bass J, Lee C, Oo S S, Lin K, Kohrt B, Michalopolous L, Nguyen A J, Bolton P
Department of Mental Health, Johns Hopkins Bloomberg School of Public Health, 624 N. Broadway, Baltimore, MD, USA.
Department of International Health, Johns Hopkins Bloomberg School of Public Health, 615 N. Wolfe St., Baltimore, MD, USA.
Glob Ment Health (Camb). 2017 Sep 11;4:e17. doi: 10.1017/gmh.2017.16. eCollection 2017.
Self-report measurement instruments are commonly used to screen for mental health disorders in Low and Middle-Income Countries (LMIC). The Western origins of most depression instruments may constitute a bias when used globally. Western measures based on the DSM, do not fully capture the expression of depression globally. We developed a self-report scale design to address this limitation, the International Depression Symptom Scale-General version (IDSS-G), based on empirical evidence of the signs and symptoms of depression reported across cultures. This paper describes the rationale and process of its development and the results of an initial test among a non-Western population.
We evaluated internal consistency reliability, test-retest reliability and inter-rater reliability of the IDSS-G in a sample = 147 male and female attendees of primary health clinics in Yangon, Myanmar. For criterion validity, IDSS-G scores were compared with diagnosis by local psychiatrists using the Structured Clinical Interview for DSM (SCID). Construct validity was evaluated by investigating associations between the IDSS-G and the Patient Health Questionnaire (PHQ), impaired function, and suicidal ideation.
The IDSS-G showed high internal consistency reliability ( = 0.92), test-retest reliability ( = 0.87), and inter-rater reliability ( = 0.90). Strong correlations between the IDSS-G and PHQ-9, functioning, and suicidal ideation supported construct validity. Criterion validity was supported for use of the IDSS-G to identify people with a SCID diagnosed depressive disorder (major depression/dysthymia). The IDSS-G also demonstrated incremental validity by predicting functional impairment beyond that predicted by the PHQ-9. Results suggest that the IDSS-G accurately assesses depression in this population. Future testing in other populations will follow.
自我报告测量工具常用于中低收入国家(LMIC)筛查心理健康障碍。大多数抑郁症测量工具起源于西方,在全球使用时可能会产生偏差。基于《精神疾病诊断与统计手册》(DSM)的西方测量方法不能完全涵盖全球范围内抑郁症的表现。我们基于不同文化中报告的抑郁症症状和体征的实证证据,开发了一种自我报告量表设计,即国际抑郁症状量表通用版(IDSS-G),以解决这一局限性。本文描述了其开发的基本原理和过程,以及在非西方人群中进行初步测试的结果。
我们在缅甸仰光初级保健诊所的147名男性和女性参与者样本中评估了IDSS-G的内部一致性信度、重测信度和评分者间信度。为了评估效标效度,将IDSS-G得分与当地精神科医生使用《精神疾病诊断与统计手册》结构化临床访谈(SCID)做出的诊断进行比较。通过研究IDSS-G与患者健康问卷(PHQ)、功能受损和自杀意念之间的关联来评估结构效度。
IDSS-G显示出高内部一致性信度(=0.92)、重测信度(=0.87)和评分者间信度(=0.90)。IDSS-G与PHQ-9、功能和自杀意念之间的强相关性支持了结构效度。支持使用IDSS-G来识别经SCID诊断为抑郁症(重度抑郁症/恶劣心境)的人的效标效度。IDSS-G还通过预测超出PHQ-9预测的功能损害显示出增量效度。结果表明,IDSS-G能够准确评估该人群中的抑郁症。未来将在其他人群中进行测试。